Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Surufatinib with chemotherapy in advanced colorectal cancer
NCT04734249Phase 2Unknown
- Sponsor
- Fujian Medical University Cancer Hospital
- Start
- Mar 2021
- Primary completion
- Mar 2021
- Modality
- Fragment-Derived Small Molecules, Allosteric Modulators, Orthosteric Ligands
01
Overview
A Phase 2 trial of surufatinib in colorectal cancer (metastatic) (mCRC), sponsored by Fujian Medical University Cancer Hospital. Status: unknown.
02
Drugs
surufatinib
03
Conditions
colorectal cancer (metastatic) (mCRC)
Beyond the preview
Go deeper on NCT04734249.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04734249.